table of content
1 Introduction to Research & Analysis Reports
1.1 Cell and Gene Therapy Drug Delivery Devices Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell and Gene Therapy Drug Delivery Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cell and Gene Therapy Drug Delivery Devices Overall Market Size
2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size: 2023 VS 2030
2.2 Global Cell and Gene Therapy Drug Delivery Devices Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cell and Gene Therapy Drug Delivery Devices Players in Global Market
3.2 Top Global Cell and Gene Therapy Drug Delivery Devices Companies Ranked by Revenue
3.3 Global Cell and Gene Therapy Drug Delivery Devices Revenue by Companies
3.4 Top 3 and Top 5 Cell and Gene Therapy Drug Delivery Devices Companies in Global Market, by Revenue in 2023
3.5 Global Companies Cell and Gene Therapy Drug Delivery Devices Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell and Gene Therapy Drug Delivery Devices Players in Global Market
3.6.1 List of Global Tier 1 Cell and Gene Therapy Drug Delivery Devices Companies
3.6.2 List of Global Tier 2 and Tier 3 Cell and Gene Therapy Drug Delivery Devices Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cell and Gene Therapy Drug Delivery Devices Market Size Markets, 2023 & 2030
4.1.2 Sterile Insulin Syringe
4.1.3 Pre-Filled Syringe
4.1.4 Infusion Bags
4.2 By Type - Global Cell and Gene Therapy Drug Delivery Devices Revenue & Forecasts
4.2.1 By Type - Global Cell and Gene Therapy Drug Delivery Devices Revenue, 2019-2024
4.2.2 By Type - Global Cell and Gene Therapy Drug Delivery Devices Revenue, 2025-2030
4.2.3 By Type - Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cell and Gene Therapy Drug Delivery Devices Market Size, 2023 & 2030
5.1.2 Luxturna
5.1.3 Kymriah
5.1.4 Provenge
5.1.5 Zolgensma
5.1.6 Yescarta
5.1.7 Strimvelis
5.2 By Application - Global Cell and Gene Therapy Drug Delivery Devices Revenue & Forecasts
5.2.1 By Application - Global Cell and Gene Therapy Drug Delivery Devices Revenue, 2019-2024
5.2.2 By Application - Global Cell and Gene Therapy Drug Delivery Devices Revenue, 2025-2030
5.2.3 By Application - Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Cell and Gene Therapy Drug Delivery Devices Market Size, 2023 & 2030
6.2 By Region - Global Cell and Gene Therapy Drug Delivery Devices Revenue & Forecasts
6.2.1 By Region - Global Cell and Gene Therapy Drug Delivery Devices Revenue, 2019-2024
6.2.2 By Region - Global Cell and Gene Therapy Drug Delivery Devices Revenue, 2025-2030
6.2.3 By Region - Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Cell and Gene Therapy Drug Delivery Devices Revenue, 2019-2030
6.3.2 US Cell and Gene Therapy Drug Delivery Devices Market Size, 2019-2030
6.3.3 Canada Cell and Gene Therapy Drug Delivery Devices Market Size, 2019-2030
6.3.4 Mexico Cell and Gene Therapy Drug Delivery Devices Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Cell and Gene Therapy Drug Delivery Devices Revenue, 2019-2030
6.4.2 Germany Cell and Gene Therapy Drug Delivery Devices Market Size, 2019-2030
6.4.3 France Cell and Gene Therapy Drug Delivery Devices Market Size, 2019-2030
6.4.4 U.K. Cell and Gene Therapy Drug Delivery Devices Market Size, 2019-2030
6.4.5 Italy Cell and Gene Therapy Drug Delivery Devices Market Size, 2019-2030
6.4.6 Russia Cell and Gene Therapy Drug Delivery Devices Market Size, 2019-2030
6.4.7 Nordic Countries Cell and Gene Therapy Drug Delivery Devices Market Size, 2019-2030
6.4.8 Benelux Cell and Gene Therapy Drug Delivery Devices Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Cell and Gene Therapy Drug Delivery Devices Revenue, 2019-2030
6.5.2 China Cell and Gene Therapy Drug Delivery Devices Market Size, 2019-2030
6.5.3 Japan Cell and Gene Therapy Drug Delivery Devices Market Size, 2019-2030
6.5.4 South Korea Cell and Gene Therapy Drug Delivery Devices Market Size, 2019-2030
6.5.5 Southeast Asia Cell and Gene Therapy Drug Delivery Devices Market Size, 2019-2030
6.5.6 India Cell and Gene Therapy Drug Delivery Devices Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Cell and Gene Therapy Drug Delivery Devices Revenue, 2019-2030
6.6.2 Brazil Cell and Gene Therapy Drug Delivery Devices Market Size, 2019-2030
6.6.3 Argentina Cell and Gene Therapy Drug Delivery Devices Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue, 2019-2030
6.7.2 Turkey Cell and Gene Therapy Drug Delivery Devices Market Size, 2019-2030
6.7.3 Israel Cell and Gene Therapy Drug Delivery Devices Market Size, 2019-2030
6.7.4 Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Market Size, 2019-2030
6.7.5 UAE Cell and Gene Therapy Drug Delivery Devices Market Size, 2019-2030
7 Cell and Gene Therapy Drug Delivery Devices Companies Profiles
7.1 Amgen, Inc.
7.1.1 Amgen, Inc. Company Summary
7.1.2 Amgen, Inc. Business Overview
7.1.3 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.1.4 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2019-2024)
7.1.5 Amgen, Inc. Key News & Latest Developments
7.2 Bausch and Lomb Incorporated
7.2.1 Bausch and Lomb Incorporated Company Summary
7.2.2 Bausch and Lomb Incorporated Business Overview
7.2.3 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.2.4 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2019-2024)
7.2.5 Bausch and Lomb Incorporated Key News & Latest Developments
7.3 Becton, Dickinson and Company
7.3.1 Becton, Dickinson and Company Company Summary
7.3.2 Becton, Dickinson and Company Business Overview
7.3.3 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.3.4 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2019-2024)
7.3.5 Becton, Dickinson and Company Key News & Latest Developments
7.4 Bluebird bio, Inc.
7.4.1 Bluebird bio, Inc. Company Summary
7.4.2 Bluebird bio, Inc. Business Overview
7.4.3 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.4.4 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2019-2024)
7.4.5 Bluebird bio, Inc. Key News & Latest Developments
7.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
7.5.1 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Company Summary
7.5.2 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Business Overview
7.5.3 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.5.4 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2019-2024)
7.5.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Key News & Latest Developments
7.6 Dendreon Pharmaceuticals LLC.
7.6.1 Dendreon Pharmaceuticals LLC. Company Summary
7.6.2 Dendreon Pharmaceuticals LLC. Business Overview
7.6.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.6.4 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2019-2024)
7.6.5 Dendreon Pharmaceuticals LLC. Key News & Latest Developments
7.7 Helixmith Co., Ltd (ViroMed Co., Ltd)
7.7.1 Helixmith Co., Ltd (ViroMed Co., Ltd) Company Summary
7.7.2 Helixmith Co., Ltd (ViroMed Co., Ltd) Business Overview
7.7.3 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.7.4 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2019-2024)
7.7.5 Helixmith Co., Ltd (ViroMed Co., Ltd) Key News & Latest Developments
7.8 Human Stem Cell Institute
7.8.1 Human Stem Cell Institute Company Summary
7.8.2 Human Stem Cell Institute Business Overview
7.8.3 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.8.4 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2019-2024)
7.8.5 Human Stem Cell Institute Key News & Latest Developments
7.9 Kite Pharma, Inc.
7.9.1 Kite Pharma, Inc. Company Summary
7.9.2 Kite Pharma, Inc. Business Overview
7.9.3 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.9.4 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2019-2024)
7.9.5 Kite Pharma, Inc. Key News & Latest Developments
7.10 Kolon Tissue Gene, inc.
7.10.1 Kolon Tissue Gene, inc. Company Summary
7.10.2 Kolon Tissue Gene, inc. Business Overview
7.10.3 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.10.4 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2019-2024)
7.10.5 Kolon Tissue Gene, inc. Key News & Latest Developments
7.11 Novartis AG
7.11.1 Novartis AG Company Summary
7.11.2 Novartis AG Business Overview
7.11.3 Novartis AG Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.11.4 Novartis AG Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2019-2024)
7.11.5 Novartis AG Key News & Latest Developments
7.12 Orchard Therapeutics plc.
7.12.1 Orchard Therapeutics plc. Company Summary
7.12.2 Orchard Therapeutics plc. Business Overview
7.12.3 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.12.4 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2019-2024)
7.12.5 Orchard Therapeutics plc. Key News & Latest Developments
7.13 Pfizer, Inc.
7.13.1 Pfizer, Inc. Company Summary
7.13.2 Pfizer, Inc. Business Overview
7.13.3 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.13.4 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2019-2024)
7.13.5 Pfizer, Inc. Key News & Latest Developments
7.14 Renova Therapeutics
7.14.1 Renova Therapeutics Company Summary
7.14.2 Renova Therapeutics Business Overview
7.14.3 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.14.4 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2019-2024)
7.14.5 Renova Therapeutics Key News & Latest Developments
7.15 Spark Therapeutics, Inc.
7.15.1 Spark Therapeutics, Inc. Company Summary
7.15.2 Spark Therapeutics, Inc. Business Overview
7.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.15.4 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2019-2024)
7.15.5 Spark Therapeutics, Inc. Key News & Latest Developments
7.16 uniQure N.V.
7.16.1 uniQure N.V. Company Summary
7.16.2 uniQure N.V. Business Overview
7.16.3 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.16.4 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2019-2024)
7.16.5 uniQure N.V. Key News & Latest Developments
7.17 Vericel Corporation
7.17.1 Vericel Corporation Company Summary
7.17.2 Vericel Corporation Business Overview
7.17.3 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.17.4 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2019-2024)
7.17.5 Vericel Corporation Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
